FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
International Journal of Molecular Sciences · 05.05.2023 · 24 (9) · 8307
DOI: 10.3390/ijms24098307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.05.2023. Verfasst von Laura Casalino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetics and Biophysics "A. Buzzati Traverso", Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino, 111, 80131 Naples, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Among FOS-related components of the dimeric AP-1 transcription factor, the oncoprotein FRA-1 (encoded by FOSL1) is a key regulator of invasion and metastasis. The well-established FRA-1 pro-invasive activity in breast cancer, in which FOSL1 is overexpressed in the TNBC (Triple Negative Breast Cancer)/basal subtypes, correlates with the FRA-1-dependent transcriptional regulation of EMT (Epithelial-to-Mesenchymal Transition). After summarizing the major findings on FRA-1 in breast cancer invasiveness, we discuss the FRA-1 mechanistic links with EMT and cancer cell stemness, mediated by transcriptional and posttranscriptional interactions between FOSL1/FRA-1 and EMT-regulating transcription factors, miRNAs, RNA binding proteins and cytokines, along with other target genes involved in EMT. In addition to the FRA-1/AP-1 effects on the architecture of target promoters, we discuss the diagnostic and prognostic significance of the EMT-related FRA-1 transcriptome, along with therapeutic implications. Finally, we consider several novel perspectives regarding the less explored roles of FRA-1 in the tumor microenvironment and in control of the recently characterized hybrid EMT correlated with cancer cell plasticity, stemness, and metastatic potential. We will also examine the application of emerging technologies, such as single-cell analyses, along with animal models of TNBC and tumor-derived CTCs and PDXs (Circulating Tumor Cells and Patient-Derived Xenografts) for studying the FRA-1-mediated mechanisms in in vivo systems of EMT and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genetics and Biophysics "A. Buzzati Traverso", Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino, 111, 80131 Naples, Italy.
ORCID-Profile: Laura Casalino
Zitieren
APA
Casalino, L., Talotta, F., Matino, I., & Verde, P. (2023). FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer. International Journal of Molecular Sciences, 24(9), 8307. https://doi.org/10.3390/ijms24098307
Vancouver
Casalino L, Talotta F, Matino I, Verde P. FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer. International Journal of Molecular Sciences. 2023;24(9):8307. doi:10.3390/ijms24098307
BibTeX
@article{Casalino2023,
author = {Casalino, Laura and Talotta, Francesco and Matino, Ilenia and Verde, Pasquale},
title = {FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {9},
pages = {8307},
doi = {10.3390/ijms24098307}
}
EUVIMED